Loading...
http://jcps.bjmu.edu.cn

Table of Content

    03 November 2025, Volume 34 Issue 10
    Review
    An overview of the processing, chemical constituents, pharmacological properties, and clinical studies of white tea
    Eric Wei Chiang Chan, Siu Kuin Wong, Hung Tuck Chan
    2025, 34(10):  897-910.  DOI: 10.5246/jcps.2025.10.066
    Asbtract ( 13 )   HTML ( 1)  
    Figures and Tables | References | Related Articles | Metrics

    This review provided an updated synthesis of current knowledge regarding the processing, chemical constituents, pharmacological properties, and clinical applications of white tea (Camellia sinensis), commonly known as WT. Information was collated from reliable sources, including Google, Google Scholar, PubMed, PubMed Central, Science Direct, PubChem, J-Stage, the Directory of Open Access Journals (DOAJ), and the China National Knowledge Infrastructure (CNKI). In China, WT, referred to as “Bai Cha”, is a prized spring tea harvested during early spring when the young tea plant leaf buds are still covered with delicate, downy white hairs. Fujian Province serves as the primary production region. WT processing is minimal, involving withering as the most crucial step, followed by drying. This simple process preserves its unique qualities and chemical integrity. The dominant phenolic compounds in WT are flavonoids, including catechins, dimeric catechins, flavones, flavonols, and flavanones. Additional constituents encompass phenolic acids, alkaloids, glycosides, and amino acids. These bioactive compounds contribute to WT’s diverse pharmacological properties, including anti-diabetic, anti-cancer, hepatoprotective, neuroprotective, anti-obesity, and male reproductive health benefits. To date, seven clinical studies have investigated the therapeutic potential of WT. These include two studies each on its use as a mouth rinse and its anti-obesity effects, and one study each focusing on its applications in managing diabetes, periodontitis, and depression. Perspectives on WT’s broader implications and opportunities for future research are also explored, highlighting its potential for expanded therapeutic applications.

    Original articles
    Effects of storage temperature on the quality stability of nanoparticle aluminum hydroxide adjuvant
    Xifei Yang, Feiwei Zhang
    2025, 34(10):  911-920.  DOI: 10.5246/jcps.2025.10.067
    Asbtract ( 11 )   HTML ( 3)  
    Figures and Tables | References | Related Articles | Metrics

    The aluminum hydroxide adjuvant possesses a poorly crystalline boehmite (PCB) structure, the stability of which is significantly affected by storage conditions. In the present study, we conducted a comprehensive investigation into the structural and quality alterations of aluminum hydroxide adjuvants under varying temperature conditions over time. Three batches of the adjuvant were stored at 2–8 °C, 18–25 °C, and 37 °C, respectively, for 6 months. Key parameters, including X-ray diffraction patterns, pH, isoelectric point (pI), adsorption capacity, and average particle size, were analyzed to assess the impact of storage temperatures. X-ray diffraction analysis confirmed the PCB structure of the aluminum hydroxide adjuvant. Notably, after 1 month of storage at 37 °C, new diffraction peaks emerged at 18.2 °2θ, with their intensity increasing progressively over time. Concurrently, the largest decreases in pI and pH were observed, measuring 0.78 and 1.33, respectively. In contrast, adjuvants stored at 2–8 °C for 6 months exhibited only faint diffraction peaks at 18.2 °2θ, indicating minor structural changes. Under these conditions, the reductions in pI and pH were comparatively smaller, at 0.43 and 0.80, respectively. The average particle size of the adjuvants remained within 110–140 nm across all storage conditions. Additionally, the aluminum hydroxide adjuvant consistently demonstrated a high protein adsorption capacity, approximately 8 mg BSA/mg Al3+, with no statistically significant differences in adsorption rates observed among the different temperature conditions (P > 0.05). These findings highlighted the remarkable adsorption efficiency of nanoparticle aluminum hydroxide adjuvants throughout storage, reinforcing their potential as superior vaccine adsorbents. However, elevated storage temperatures were shown to accelerate structural aging, promoting the formation of highly crystalline phases such as gibbsite or bayerite, which could compromise the stability and quality of the adjuvant.

    Quantification of Voriconazole in rat plasma using HPLC and pharmacokinetic analysis
    Chenxi Liu, Huan Liu, Tianping Chen, Shiyi He, Jiangling Hu, Xinhui Jiang
    2025, 34(10):  921-931.  DOI: 10.5246/jcps.2025.10.068
    Asbtract ( 25 )   HTML ( 13)  
    Figures and Tables | References | Related Articles | Metrics

    This study aimed to establish a reliable high-performance liquid chromatography (HPLC) method for determining Voriconazole concentrations in rat plasma, employing an internal standard approach to enhance accuracy. The pharmacokinetics of Voriconazole were also investigated. The method utilized Fluconazole as the internal standard, with gradient elution of a methanol-water mobile phase (0–2.5 min: 50% methanol; 2.5–4 min: 50%–70% methanol; after 4 min: 70% methanol). The analysis was performed at 30 °C with a flow rate of 1.0 mL/min, a detection wavelength of 254 nm, and a 20-μL injection volume. Following a single oral dose of Voriconazole (40 mg/kg), plasma concentrations were measured at various time points and analyzed using DAS2.0 software to calculate pharmacokinetic parameters. The method demonstrated excellent linearity (R2 = 0.9992) over the concentration range of 0.2–40 mg/L. The extraction recoveries ranged from 85% to 115%, and intra-day and inter-day relative standard deviations (RSDs) were below 10%. Pharmacokinetic analysis revealed a distribution half-life of 69.315 min, an elimination half-life of 69.315 min, and an AUC0–t of 8040.73 min·mg/L after oral administration at 40 mg/kg. The proposed HPLC method was simple, rapid, and precise, making it suitable for pharmacokinetic studies of Voriconazole in rats. Furthermore, this method offered potential applicability for clinical batch detection of Voriconazole in blood samples.

    Unveiling the mechanisms of Bidentate Achyranthes and American Ginseng therapy in Sjögren’s Syndrome: insights from network pharmacology and molecular docking
    Haotian Li, Qianxing Liu, Congmin Xia, Sile Hu, Yanjun Liu, Quan Jiang
    2025, 34(10):  932-942.  DOI: 10.5246/jcps.2025.10.069
    Asbtract ( 1 )   HTML ( 1)  
    Figures and Tables | References | Related Articles | Metrics

    Sjögren’s syndrome (SS) is a challenging condition within the realm of rheumatologic immune disorders. Recent studies have indicated that the imbalance in the immune microenvironment, exacerbated by mitochondrial dysfunction (MDF), plays a critical role in the pathogenesis of SS. The efficacy of traditional Chinese medicine (TCM) in treating SS has been noteworthy. In the present study, we compiled medical cases of SS treated by Lu Zhizheng, a renowned master of Chinese medicine, and identified bidentate achyranthes and American ginseng as high-frequency medicinal pairs utilized in the treatment of desiccation syndrome through data mining. Network pharmacology analysis revealed that key genes associated with these medicinal pairs were linked to both upstream and downstream components of the cGAS-STING signaling pathway. Our findings suggested that bidentate achyranthes and American ginseng might correct MDF through the mtDNA-cGAS-STING signaling axis, thereby restoring the balance of the immune microenvironment in the submandibular gland. This mechanism potentially led to the treatment and alleviation of symptoms associated with SS.

    Application of nano-flow cytometry for the detection of extracellular vesicles and lipid nanoparticles
    Yufang Sun, Yingli Xu, Hualong Yu, Shuxiang Song
    2025, 34(10):  943-953.  DOI: 10.5246/jcps.2025.10.070
    Asbtract ( 0 )   HTML ( 1)  
    Figures and Tables | References | Related Articles | Metrics

    Lipid nanoparticles (LNPs) and extracellular vesicles (EVs) have emerged as powerful therapeutic platforms, each offering distinct advantages. LNPs, composed of four essential lipid components, enable efficient delivery of drugs and genetic materials, underpinning FDA-approved therapies such as Onpattro and the COVID-19 mRNA vaccines. EVs, naturally secreted by cells, transport bioactive molecules with remarkable delivery efficiency and reduced off-target effects, as exemplified by the EV-based Bexsero vaccine. Given their small size and intrinsic heterogeneity, precise characterization is critical. Compared to conventional techniques like nanoparticle tracking analysis (NTA) and dynamic light scattering (DLS), flow cytometry (FCM) offers a more comprehensive analytical profile for both LNPs and EVs. In the present study, we leveraged a nano-FCM to advance detection strategies for nanoscale therapeutics. A detailed workflow is presented to ensure analytical precision and reproducibility.